Bullet flag-united-kingdom flag-ireland

Intended for patients and carers of patients prescribed a Chiesi product

Patient Resources

Myalepta®

Metreleptin

Your doctor, nurse or pharmacist has prescribed Myalepta to help treat the problems caused by leptin deficiency in lipodystrophy. Administered as prescribed, Myalepta can help to manage your symptoms and this page contains information to help you. Your care will be supervised by a team who are lipodystrophy specialists and you should always follow their advice including around diet and the preparation and administration of the product.

Remember, should you need additional advice regarding your condition or treatment, please speak to your doctor, nurse or pharmacist.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

REPORTING OF SIDE EFFECTS: IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR, PHARMACIST OR NURSE. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THE PACKAGE LEAFLET. YOU CAN ALSO REPORT SIDE EFFECTS DIRECTLY VIA THE YELLOW CARD SCHEME AT https://yellowcard.mhra.gov.uk/ FOR THE UK, OR VIA WWW.HPRA.IE FOR IRELAND.

BY REPORTING SIDE EFFECTS, YOU CAN HELP PROVIDE MORE INFORMATION ON THE SAFETY OF THIS MEDICINE.